-
Mashup Score: 13Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years | Pfizer - 3 year(s) ago
Results are the first from a pivotal trial of any COVID-19 vaccine in children under 12 years of age In participants 5 to 11 years of age, the vaccine was safe, well tolerated and showed robust neutralizing antibody responses Companies plan to submit these data to the FDA, EMA and other regulatory agencies around the world as soon as possible Results in children under 5 years of age are expected…
Source: www.pfizer.comCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 0
The agency is rolling back emergency use authorizations for some Covid-19 tests, and decontamination systems used to sterilize N95 masks for re-use, among other devices. Hospitals will need a system to keep close track of which devices they’re using and which ones are no longer authorized.
Source: MedCity NewsCategories: Future of Medicine, Latest HeadlinesTweet-
#FDA revokes more #EUA authorized #medicaldevices - agency is rolling back EUA for some #Covid19 #diagnostics tests, decontamination sys to sterilize #N95 masks; hospitals will need sys to track which devices they’re using, which ones no longer authorized https://t.co/aSTGhEOOWa
-
-
Mashup Score: 0
EUAs can enable people to get immediate access to preventive therapy or treatment, but is it always worth aiming for full approval?
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
Dr. Susan Wood @GWpublichealth discusses the ramifications of #FDA #EUA and how it compares to FDA approval. https://t.co/XahzptwG54
-
-
Mashup Score: 0
Amazon subsidiary STS Lab Holdco received FDA emergency use authorization (EUA) for the direct-to-consumer sale of its COVID-19 test.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Amazon wins #EUA to sell its #COVID19 #diagnostics test directly to consumers | #hometesting https://t.co/bc4Y4rgSrw
-
-
Mashup Score: 0
The companies announce plans to submit a Biologics License Agreement for the mRNA-based vaccine.
Source: HCPLiveCategories: General Medicine News, Latest HeadlinesTweet-
The first #COVID19 vaccine to gain an #EUA might be the first gain full #FDA approval. https://t.co/64ifdT13J2
-
-
Mashup Score: 2
The Advisory Committee on Immunization Practices voted 10-4 with 1 abstention to resume the rollout and administration of the Janssen shot.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
The #ACIP voted 10-4 with 1 abstention to reaffirm recommendation of the #Janssen vaccine in persons 18 years of age and older in the US population under the FDA’s #EUA. https://t.co/UtZjBRFjaJ
-
-
Mashup Score: 0Amazon lands EUA for COVID-19 test with home sample collection - 3 year(s) ago
According to FDA documents, the test is intended to help stop the spread of COVID-19 among Amazon employees.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Amazon lands #EUA for #COVID19 #diagnostics test with home sample collection https://t.co/pkqBz76qkI
-
-
Mashup Score: 1
The therapy showed significant efficacy in a Phase 3 trial and may be more difficult for variants to develop a resistance against.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#GlaxoSmithKline and #Vir Biotechnology have announced that they submitted an application to #FDA requesting an #EUA for their investigational dual-action SARS-CoV-2 monoclonal antibody. #COVID19 https://t.co/77wq6VIM3Q
-
-
Mashup Score: 1AstraZeneca Updates its COVID-19 Vaccine Efficacy - 3 year(s) ago
Overnight, the company restated it had a 76% efficacy against symptomatic disease and is looking to file an Emergency Use Authorization (EUA) with Food and Drug Administration (FDA).
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Breaking #AstraZeneca updated its data reporting saying its #COVID19 #vaccine demonstrated a 76% efficacy against symptomatic disease, and plans an #FDA #EUA https://t.co/UouxV2axNR
-
-
Mashup Score: 0Trends in Health Care Worker Intentions to Receive a COVID-19 Vaccine and Reasons for Hesitancy - 3 year(s) ago
This survey study queried employees of a health care system before COVID-19 vaccine distribution to assess their intentions to receive a vaccine and to understand their reasons for hesitancy to do so.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Dec 10 survey of health care workers to guide #COVID19 vaccine distribution finds higher rates of intent to receive vaccine than previously; substantially increased intent as transparent #EUA processes unfolded. @MichelleNMeyer @DanRosica_ @GeisingerHealth https://t.co/rX1qvx0W86
-
Come on @US_FDA - time for an #EUA https://t.co/dO9rtkLmRY